Literature DB >> 11793166

Early-onset schizophrenia as a progressive-deteriorating developmental disorder: evidence from child psychiatry.

H Remschmidt1.   

Abstract

The developmental perspective as reflected by investigations of childhood and early-onset schizophrenia has become a major research area during recent years and contributed much to the understanding of schizophrenia at all ages. This paper reviews clinical features, neurobiological and neuropsychological findings in childhood and adolescent onset schizophrenia including some results of studies of the author on age at onset, premorbid symptoms, treatment and course. Childhood-onset schizophrenia is a rare disorder with a prevalence of one child in 10,000 before the age of 12 and a remarkable increase around puberty and early adolescence. Developmental events and precursors of schizophrenia cover a wide range of dysfunctions and disturbances including elevated rates of soft neurological signs and birth complications, slow habituation and high baseline autonomic activity, high rate of developmental disorders of speech and/or language and overall and specific cognitive deficits. Brain morphological studies and intelligence testing as well as investigations of the course provide evidence of deterioration. Therefore, early-onset schizophrenia can be understood as a progressive-deteriorating developmental disorder.

Entities:  

Mesh:

Year:  2002        PMID: 11793166     DOI: 10.1007/s702-002-8240-3

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  18 in total

1.  Semantic Processing and Thought Disorder in Childhood-Onset Schizophrenia: Insights from fMRI.

Authors:  L A Borofsky; K McNealy; P Siddarth; K N Wu; M Dapretto; R Caplan
Journal:  J Neurolinguistics       Date:  2010-05       Impact factor: 1.710

Review 2.  Developing services for the early detection of psychosis: a critical consideration of the current state of the art.

Authors:  Andor E Simon; Binia Roth; Solange Zmilacher; Emanuel Isler; Daniel Umbricht
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-09-08       Impact factor: 4.785

3.  Neonatal exposure to MK801 promotes prepulse-induced delay in startle response time in adult rats.

Authors:  Amanda Lyall; John Swanson; Chun Liu; Terry D Blumenthal; Christopher Paul Turner
Journal:  Exp Brain Res       Date:  2009-06-30       Impact factor: 1.972

4.  Cognitive remediation for adolescents with 22q11 deletion syndrome (22q11DS): a preliminary study examining effectiveness, feasibility, and fidelity of a hybrid strategy, remote and computer-based intervention.

Authors:  Margaret A Mariano; Kerri Tang; Matthew Kurtz; Wendy R Kates
Journal:  Schizophr Res       Date:  2015-06-01       Impact factor: 4.939

5.  Forty-two-years later: the outcome of childhood-onset schizophrenia.

Authors:  H Remschmidt; M Martin; C Fleischhaker; F M Theisen; K Hennighausen; C Gutenbrunner; E Schulz
Journal:  J Neural Transm (Vienna)       Date:  2006-08-10       Impact factor: 3.575

6.  Prevalence of movement disorders in adolescent patients with schizophrenia and in relationship to predominantly atypical antipsychotic treatment.

Authors:  Stefan Gebhardt; Fabian Härtling; Markus Hanke; Markus Mittendorf; Frank M Theisen; Karin Wolf-Ostermann; Phillip Grant; Matthias Martin; Christian Fleischhaker; Eberhard Schulz; Helmut Remschmidt
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-04-28       Impact factor: 4.785

7.  Relations between movement disorders and psychopathology under predominantly atypical antipsychotic treatment in adolescent patients with schizophrenia.

Authors:  Stefan Gebhardt; Fabian Härtling; Markus Hanke; Frank M Theisen; Richard von Georgi; Phillip Grant; Markus Mittendorf; Matthias Martin; Christian Fleischhaker; Eberhard Schulz; Helmut Remschmidt
Journal:  Eur Child Adolesc Psychiatry       Date:  2007-09-14       Impact factor: 4.785

Review 8.  Management of psychiatric disorders in children and adolescents with atypical antipsychotics: a systematic review of published clinical trials.

Authors:  Peter S Jensen; Jan Buitelaar; Gahan J Pandina; Carin Binder; Magali Haas
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-10-30       Impact factor: 4.785

9.  Postnatal exposure to MK801 induces selective changes in GAD67 or parvalbumin.

Authors:  Christopher Paul Turner; Danielle DeBenedetto; Emily Ware; Robert Stowe; Andrew Lee; John Swanson; Caroline Walburg; Alexandra Lambert; Melissa Lyle; Priyanka Desai; Chun Liu
Journal:  Exp Brain Res       Date:  2009-11-03       Impact factor: 1.972

10.  Reduced N-acetyl-aspartate levels in schizophrenia patients with a younger onset age: a single-voxel 1H spectroscopy study.

Authors:  Jeffrey A Stanley; Madhuri Vemulapalli; Jeffrey Nutche; Debra M Montrose; John A Sweeney; Jay W Pettegrew; Frank P MacMaster; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2007-05-10       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.